Structures by: Brooks N. R.
Total: 110
Bis(1,5-Dimethoxy-3-oxapentane)-lithium iodide
I,C12H28LiO6
The Journal of Physical Chemistry C (2014) 118, 35 20152
a=10.1824(7)Å b=12.0243(8)Å c=14.6817(15)Å
α=90.00° β=90.00° γ=90.00°
1,2,4-Triazolium perfluorobutanesulfonate
C2H4N3,C4F9O3S
Energy Environ. Sci. (2015) 8, 4 1276
a=5.2742(4)Å b=8.2719(5)Å c=29.673(2)Å
α=90.00° β=93.124(7)° γ=90.00°
1,2,4-Triazolium perfluorobutanesulfonate
C2H4N3,C4F9O3S
Energy Environ. Sci. (2015) 8, 4 1276
a=5.3510(3)Å b=8.2492(5)Å c=30.2383(18)Å
α=90.00° β=93.950(5)° γ=90.00°
01358
C12H28LiClO10
The Journal of Physical Chemistry A (2004) 108, 1 225
a=31.229(4)Å b=12.075(2)Å c=15.127(2)Å
α=90.00° β=90.00° γ=90.00°
01392
C8H20ClLiO8
The Journal of Physical Chemistry A (2004) 108, 1 225
a=13.147(1)Å b=8.9501(9)Å c=12.378(1)Å
α=90.00° β=108.090(2)° γ=90.00°
01194
C24H16O3
Organic Letters (2002) 4, 20 3521
a=8.1438(11)Å b=11.5962(16)Å c=18.591(3)Å
α=90.00° β=95.066(2)° γ=90.00°
Tetrakis(N-methylimidazole) palladium(II) bistriflimide
C16H24N8Pd,2(C2F6NO4S2)
Chemical communications (Cambridge, England) (2014) 50, 71 10248-10250
a=9.1556(2)Å b=10.8229(2)Å c=17.9774(3)Å
α=90.00° β=99.330(2)° γ=90.00°
Tetrakis(N-ethylimidazole) palladium(II) bistriflimide
C20H32N8Pd,2(C2F6NO4S2)
Chemical communications (Cambridge, England) (2014) 50, 71 10248-10250
a=8.8459(5)Å b=9.1693(6)Å c=14.3228(9)Å
α=92.776(5)° β=106.337(5)° γ=113.370(6)°
Bis(N-methylimidazole) bis(N-ethylimidazole) palladium(II) bistriflimide
C18H28N8Pd,2(C2F6NO4S2)
Chemical communications (Cambridge, England) (2014) 50, 71 10248-10250
a=10.2427(8)Å b=11.3109(5)Å c=15.6582(9)Å
α=90.00° β=90.056(6)° γ=90.00°
02080
C21H40Cl2N4O2Zn2,C4H8O
Chemical Communications (2002) 18 2132
a=17.3944(17)Å b=14.6134(14)Å c=11.9982(12)Å
α=90.00° β=90.00° γ=90.00°
[(Cu4I4)(bpds)2]
C22H19Cu4I4N5S4
Chemical Communications (2001) 16 1432
a=8.878(1)Å b=10.212(1)Å c=19.307(2)Å
α=90.249(2)° β=103.023(2)° γ=92.796(2)°
Cuipss
(CuI)(NC5H4SSH4C5N).MeCN
Chemical Communications (2001) 16 1432
a=8.745(2)Å b=8.955(4)Å c=10.636(3)Å
α=94.48(4)° β=96.63(3)° γ=106.11(4)°
(CuI)bpds.CH2CL2
(CuI)(NC5H4C5H4N)(CH2Cl2)
Chemical Communications (2001) 16 1432
a=8.4250(17)Å b=10.318(2)Å c=10.670(2)Å
α=113.92(3)° β=97.23(3)° γ=92.21(3)°
(CUI)4(bpds)
Cu4I4(NC5H4SSC5H4N).0.5EtCN
Chemical Communications (2001) 16 1432
a=19.493(4)Å b=10.760(2)Å c=17.334(4)Å
α=90.00° β=90.00° γ=90.00°
Tin 1-methoxy-2-(2-methoxyethoxy)ethane ethanolbis(trifluoromethylsulfonyl)imide
C8H20O4Sn,2(C2F6NO4S2)
Chemical communications (Cambridge, England) (2017) 53, 5 913-916
a=9.1134(3)Å b=9.5041(4)Å c=18.0048(7)Å
α=85.032(3)° β=80.364(3)° γ=67.851(4)°
Acetonitrile silver bistriflimide
C4H3AgF6N2O4S2
Physical chemistry chemical physics : PCCP (2012) 14, 5 1706-1715
a=7.6535(3)Å b=18.7315(8)Å c=8.4452(4)Å
α=90.00° β=99.254(2)° γ=90.00°
Bis(1-ethylimidazome)silver bistrifimide
C10H16AgN4,C2F6NO4S2
Physical chemistry chemical physics : PCCP (2012) 14, 5 1706-1715
a=14.9257(3)Å b=8.6793(2)Å c=16.5837(3)Å
α=90.00° β=108.6980(10)° γ=90.00°
Tetrakis(N-methylimidazole)copper(II) bistriflimide
C22H32CuF6N9O4S2,C2F6NO4S2
CrystEngComm (2012) 14, 15 4902
a=8.991(2)Å b=9.438(3)Å c=14.654(3)Å
α=89.594(15)° β=72.209(13)° γ=62.905(13)°
Tetrakis(N-methylimidazole)copper(II) bistriflimide
C32H48CuF12N10O8S4
CrystEngComm (2012) 14, 15 4902
a=16.0369(6)Å b=24.0453(9)Å c=25.0434(9)Å
α=90.00° β=90.651(2)° γ=90.00°
Hexakis(N-methylimidazole)cobalt(II) bistriflimide
C24H36CoN12,2(C2F6NO4S2)
CrystEngComm (2012) 14, 15 4902
a=8.2207(2)Å b=20.3211(4)Å c=27.0612(5)Å
α=90.00° β=92.363(2)° γ=90.00°
Hexakis(N-methylimidazole)nickel(II) bistriflimide
C24H36N12Ni,2(C2F6NO4S2)
CrystEngComm (2012) 14, 15 4902
a=8.2018(2)Å b=20.3183(5)Å c=26.9380(8)Å
α=90.00° β=92.341(3)° γ=90.00°
Hexakis(N-methylimidazole)copper(II) bistriflimide
C24H36CuN12,2(C2F6NO4S2)
CrystEngComm (2012) 14, 15 4902
a=8.2933(3)Å b=11.1971(3)Å c=24.1682(7)Å
α=91.145(1)° β=93.419(1)° γ=92.945(2)°
Triaqua-tris(bis(trifluoromethylsulfonyl)imide-O,O')-praseodymium(iii)
C6H6F18N3O15Pr1S6
CrystEngComm (2015) 17, 37 7142
a=18.53745(8)Å b=18.53745(8)Å c=18.53745(8)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis(N-methylimidazole)copper(II) bistriflimide
C20H24CuF12N10O8S4
CrystEngComm (2012) 14, 15 4902
a=9.1104(5)Å b=9.6323(5)Å c=10.6590(7)Å
α=68.139(4)° β=85.255(5)° γ=87.828(4)°
Triaqua-tris(bis(trifluoromethylsulfonyl)imide-O,O')-lanthanum(iii)hemi(pentahydrate)
C6H6F18La1N3O15S6,2.5(H2O)
CrystEngComm (2015) 17, 37 7142
a=15.5598(15)Å b=15.5598(15)Å c=8.2562(9)Å
α=90.00° β=90.00° γ=120.00°
Triaqua-tris(bis(trifluoromethylsulfonyl)imide-O,O')-neodinium(iii)
C6H6F18N3Nd1O15S6
CrystEngComm (2015) 17, 37 7142
a=18.4695(2)Å b=18.4695(2)Å c=18.4695(2)Å
α=90.00° β=90.00° γ=90.00°
Heptaaqua-scandium(iii) tris(bis(trifluoromethylsulfonyl)imide) hydrate
H14O7Sc,3(C2F6NO4S2),H2O
CrystEngComm (2015) 17, 37 7142
a=8.8946(4)Å b=19.9678(10)Å c=18.7790(8)Å
α=90.00° β=98.166(5)° γ=90.00°
Triaqua-tris(bis(trifluoromethylsulfonyl)imide-O,O')-gadolinium(iii)
C6H6F18Gd1N3O15S6
CrystEngComm (2015) 17, 37 7142
a=18.3973(2)Å b=18.3973(2)Å c=18.3973(2)Å
α=90.00° β=90.00° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-samarium(iii)
C6H10F18N3O17S6Sm
CrystEngComm (2015) 17, 37 7142
a=12.9489(3)Å b=18.4605(5)Å c=12.9858(3)Å
α=90.00° β=94.507(2)° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-dysprosium(iii)
C6H10DyF18N3O17S6
CrystEngComm (2015) 17, 37 7142
a=12.8735(6)Å b=18.3588(9)Å c=12.9082(6)Å
α=90.00° β=94.119(4)° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-terbium(iii)
C6H10F18N3O17S6Tb
CrystEngComm (2015) 17, 37 7142
a=12.9085(3)Å b=18.3690(4)Å c=12.9307(3)Å
α=90.00° β=94.275(2)° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-erbium(iii)
C6H10ErF18N3O17S6
CrystEngComm (2015) 17, 37 7142
a=12.8788(4)Å b=18.2797(7)Å c=12.8814(5)Å
α=90.00° β=94.524(3)° γ=90.00°
(CuI)2([16]aneS4)
C12H24S4Cu2I2
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=7.456(2)Å b=14.804(3)Å c=18.470(5)Å
α=90.00° β=98.33(3)° γ=90.00°
[12]aneS4 copper(I) iodide
C8H16S4CuI
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=8.905(3)Å b=8.905(3)Å c=8.331(3)Å
α=90.00° β=90.00° γ=90.00°
[12]aneS4 copper(I) chloride
C8H16S4CuCl
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=13.469(2)Å b=7.6268(16)Å c=13.578(2)Å
α=90.00° β=115.654(13)° γ=90.00°
[12]aneS4 tetra(copper(I) iodide)
C2H4SCuI
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=11.2982(9)Å b=11.2982(9)Å c=8.2530(10)Å
α=90.00° β=90.00° γ=90.00°
C8H16BrCuS4
C8H16BrCuS4
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=8.7331(12)Å b=8.7331(12)Å c=8.2510(17)Å
α=90.00° β=90.00° γ=90.00°
[Ag2(1,3-[6]aneS2)(BF4)(Cl)]
C8H16Ag2BClF4S4
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=14.290(2)Å b=6.919(2)Å c=16.189(2)Å
α=90.00° β=90.00° γ=90.00°
[Ag(1,3-[6]aneS2)NO3]
C4H8AgNO3S2
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=6.8622(4)Å b=7.9021(5)Å c=15.9619(9)Å
α=90.00° β=90.1210(10)° γ=90.00°
[Ag2(1,3-[6]aneS2)SO4].3H2O
C4H14Ag2O7S3
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=22.876(2)Å b=7.0102(5)Å c=16.8656(13)Å
α=90.00° β=116.449(2)° γ=90.00°
[Ag(1,3-[6]aneS2)NO2]
C4H8AgNO2S2
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=6.5119(10)Å b=13.1352(19)Å c=18.463(3)Å
α=90.00° β=90.00° γ=90.00°
C8H16Ag2B2F8S4
C8H16Ag2B2F8S4
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=6.3604(3)Å b=9.2890(5)Å c=15.9760(8)Å
α=85.8370(10)° β=84.7880(10)° γ=83.6270(10)°
C4H8AgF6PS2
C4H8AgF6PS2
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=6.5099(9)Å b=18.743(3)Å c=8.2518(12)Å
α=90.00° β=93.404(2)° γ=90.00°
C4H8AgNO3S2
C4H8AgNO3S2
Journal of the Chemical Society, Dalton Transactions (2002) 22 4134
a=6.9178(12)Å b=7.9633(15)Å c=15.994(3)Å
α=90.00° β=90.122(4)° γ=90.00°
Bis(N-butylimidazole)silver bistriflimide
C14H24AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=8.9816(7)Å b=16.8076(12)Å c=18.0174(18)Å
α=111.575(3)° β=90.026(6)° γ=97.337(4)°
(N-butylimidazole)(N-ethylimidazole)silver bistriflimide
C12H20AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=15.2285(9)Å b=8.9449(7)Å c=18.0327(11)Å
α=90.00° β=114.034(3)° γ=90.00°
Bis(N-methylimidazole)silver bistriflimide
C2F6NO4S2,C8H12AgN4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=11.9627(5)Å b=9.0478(3)Å c=17.1295(8)Å
α=90.00° β=90.760(2)° γ=90.00°
(N-butylimidazole)(N-methylimidazole)silver bistriflimide
C11H18AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=14.7961(11)Å b=9.0675(6)Å c=17.9641(15)Å
α=90.00° β=109.152(9)° γ=90.00°
Tris(copper bromide) triazine
C3N3H3Cu3Br3
Journal of the Chemical Society, Dalton Transactions (1999) 13 2103
a=16.096(3)Å b=6.5180(13)Å c=18.010(4)Å
α=90.00° β=90.00° γ=90.00°
Tri(copper(i) iodide) triazine
C3H3Cu3I3N3
Journal of the Chemical Society, Dalton Transactions (1999) 13 2103
a=6.913(4)Å b=9.777(5)Å c=15.750(9)Å
α=90.00° β=90.00° γ=90.00°
Copper Bromide Triazine
(CuBr)2(C3H3N3)
Journal of the Chemical Society, Dalton Transactions (1999) 13 2103
a=14.247(6)Å b=14.247(6)Å c=6.415(3)Å
α=90.00° β=90.00° γ=120.00°
Dicopper diiodide triazine
C3H3Cu2I2N3
Journal of the Chemical Society, Dalton Transactions (1999) 13 2103
a=15.380(4)Å b=7.7248(8)Å c=6.9130(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(pyridine-N-oxide)silver nitrate
C10H10AgN3O5
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=8.2360(4)Å b=8.7680(5)Å c=8.7895(4)Å
α=77.874(5)° β=80.894(4)° γ=72.726(5)°
C11H13AgN2O5S
C11H13AgN2O5S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=11.6002(2)Å b=6.90176(12)Å c=17.1007(4)Å
α=90.00° β=104.866(2)° γ=90.00°
C15H15AgN3O3,CF3O3S
C15H15AgN3O3,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=25.9649(5)Å b=25.9649(5)Å c=11.8154(3)Å
α=90.00° β=90.00° γ=90.00°
Tris(pyridine-N-oxide) silver bistriflimide
C15H15AgN3O3,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=25.4018(11)Å b=25.4018(11)Å c=12.5772(5)Å
α=90.00° β=90.00° γ=120.00°
C40H40Ag3N8O8,3(CF3O3S)
C40H40Ag3N8O8,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=7.0275(3)Å b=25.8608(10)Å c=14.6674(4)Å
α=90.00° β=90.519(3)° γ=90.00°
Tris(pyridine-N-oxide) silver bistriflimide
C45H45Ag3N9O9,3(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=25.5554(4)Å b=25.5554(4)Å c=56.4189(11)Å
α=90.00° β=90.00° γ=120.00°
C12H20AgN4,C2N3
C12H20AgN4,C2N3
Dalton transactions (Cambridge, England : 2003) (2014) 43, 9 3443-3452
a=20.344(2)Å b=6.9249(4)Å c=15.2990(17)Å
α=90.00° β=126.766(16)° γ=90.00°
C12H20AgN4,CNS
C12H20AgN4,CNS
Dalton transactions (Cambridge, England : 2003) (2014) 43, 9 3443-3452
a=16.7075(11)Å b=8.1360(5)Å c=13.3162(8)Å
α=90.00° β=111.810(7)° γ=90.00°
C12H20AgN4,C2H3O2
C12H20AgN4,C2H3O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 9 3443-3452
a=15.4432(7)Å b=8.6443(4)Å c=13.5597(6)Å
α=90.00° β=108.450(5)° γ=90.00°
C5N5O2S5U,3(C6H11N2)
C5N5O2S5U,3(C6H11N2)
Chem.Commun. (2011) 47, 4490
a=17.6459(12)Å b=12.6743(9)Å c=15.7555(13)Å
α=90.00° β=97.081(4)° γ=90.00°
Bis(N-methylimidazole)silver nitrate
C8H12AgN4,NO3
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=6.2877(2)Å b=7.7823(4)Å c=12.5635(5)Å
α=88.036(4)° β=89.839(3)° γ=76.687(4)°
Bis(N-butylimidazole)silver nitrate
C14H24AgN4,NO3
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=16.4340(13)Å b=7.8736(7)Å c=13.8845(13)Å
α=90.00° β=106.748(9)° γ=90.00°
Bis(N-dodecylimidazole)silver nitrate dihydrate
C30H56AgN4,NO3,2(H2O)
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=4.5579(4)Å b=8.2220(5)Å c=23.099(2)Å
α=89.274(7)° β=87.415(7)° γ=78.188(6)°
Hexakis(N-methylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C24H36N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=8.18271(10)Å b=20.1947(3)Å c=27.0549(3)Å
α=90.00° β=92.4412(10)° γ=90.00°
N-methylimidazole pentakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C29H46N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=11.0036(3)Å b=11.1127(3)Å c=20.1049(5)Å
α=90.00° β=98.316(2)° γ=90.00°
Hexakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C30H48N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=11.0834(5)Å b=11.1196(4)Å c=20.2237(7)Å
α=90.00° β=98.423(4)° γ=90.00°
Bis(N-methylimidazole) tetrakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C28H44N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=10.9682(4)Å b=11.1202(4)Å c=20.0576(6)Å
α=90.00° β=98.463(3)° γ=90.00°
4.5(N-methylimidazole) 1.5(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C25.5H39N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=8.3667(2)Å b=11.5721(3)Å c=24.0909(4)Å
α=90.00° β=95.811(2)° γ=90.00°
Dicalcium octaneodymium hexakis(orthosilicate) dioxide
Ca2.49Nd7.51O25.75Si6
Acta Crystallographica Section E (2016) 72, 2 209-211
a=9.5507(3)Å b=9.5507(3)Å c=7.0513(3)Å
α=90.00° β=90.00° γ=120.00°
Dichlorobis[1-methylimidazoline-2(3H)-thione]cadmium(II)
C8H12CdCl2N4S2
Acta Crystallographica Section E (2005) 61, 7 m1383-m1385
a=9.6464(8)Å b=7.6262(8)Å c=19.7151(8)Å
α=90.00° β=96.485(6)° γ=90.00°
Li(CF3SO3)(CH3CN)
CF3LiO3S,C2H3N
Acta Crystallographica Section E (2002) 58, 5 m176-m177
a=5.4814(11)Å b=14.790(3)Å c=9.409(2)Å
α=90.00° β=90.064(3)° γ=90.00°
PdCl2(4-CNpy)2
C12H8Cl2N4Pd
Acta Crystallographica Section E (2002) 58, 8 m385-m386
a=3.8983(13)Å b=25.651(14)Å c=7.256(4)Å
α=90.00° β=101.33(5)° γ=90.00°
2C16H36N,Br0.33Cl3.67Cu4MoS42
2C16H36N,Br0.33Cl3.67Cu4MoS42
Acta Crystallographica Section E (2004) 60, 2 m204-m206
a=13.3356(6)Å b=13.3356(6)Å c=13.6495(9)Å
α=90.00° β=90.00° γ=90.00°
3C8H20N,Br3.42Cl0.58Cu3MoOS33,C3H6O
3C8H20N,Br3.42Cl0.58Cu3MoOS33,C3H6O
Acta Crystallographica Section E (2004) 60, 2 m231-m233
a=14.2654(10)Å b=17.8039(18)Å c=17.288(2)Å
α=90.00° β=93.224(9)° γ=90.00°
(MeCN)6Fe (SbF6)2
C12H18FeN62,2F6Sb1
Acta Crystallographica Section E (2001) 57, 11 m545-m546
a=11.3398(6)Å b=11.3398(6)Å c=17.3584(11)Å
α=90.00° β=90.00° γ=120.00°
2046
C4H10LiNO5
Acta Crystallographica Section E (2002) 58, 9 m500-m501
a=7.4925(5)Å b=7.4925(5)Å c=23.989(3)Å
α=90.00° β=90.00° γ=120.00°
Bis([9]aneS~3~)nickel(II) dibromide tetrahydrate
C12H24S6Ni2,2Br1,4H2O
Acta Crystallographica Section E (2001) 57, 8 m376-m377
a=7.654(3)Å b=8.972(4)Å c=9.132(5)Å
α=93.34(4)° β=102.63(4)° γ=107.79(4)°
2C8H20N1,Cl2Cu2MoS42
2C8H20N1,Cl2Cu2MoS42
Acta Crystallographica Section E (2003) 59, 12 m1134-m1136
a=7.5052(5)Å b=13.2537(9)Å c=27.9439(18)Å
α=90.00° β=93.1750(10)° γ=90.00°
[1-methylimidazole-2(3H)-thione-2κS]dioxo-1κ^2^O-di-μ-sulfido-1:2κ^4^S:S- copper(I)tungstate(VI)
C8H20N,C4H6CuN2O2S3W
Acta Crystallographica Section E (2004) 60, 12 m1923-m1926
a=7.1985(5)Å b=16.3720(14)Å c=17.244(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(tetra-n-butylammonium) tetrakis[chloro(μ~3~-sulfido)copper(I)]tungstate(VI)
2C16H36N,Cl4Cu4S4W2
Acta Crystallographica Section E (2004) 60, 12 m1952-m1954
a=13.3652(5)Å b=13.3652(5)Å c=13.668(2)Å
α=90.00° β=90.00° γ=90.00°
01023a
C8H14F6Li2O9S2
Acta Crystallographica Section C (2002) 58, 10 m501-m503
a=8.678(3)Å b=10.815(3)Å c=11.899(4)Å
α=67.566(5)° β=89.831(5)° γ=71.435(5)°
Poly[[[bis(2-methoxyethyl) ether]lithium(I)]-di- μ-~3~-trifluoroacetato-dilithium(I)-μ~3~-trifluoroacatato]
C12H14F9Li3O9
Acta Crystallographica Section C (2002) 58, 10 m501-m503
a=9.545(4)Å b=13.871(6)Å c=15.589(7)Å
α=90° β=92.974(8)° γ=90°
Bis[<i>N</i>-(4-nitrophenyl)thiobenzamidato]mercury(II)
C26H18HgN4O4S2
Acta Crystallographica Section C (2007) 63, 11 m494-m495
a=9.7351(8)Å b=14.3655(14)Å c=17.9804(12)Å
α=90.00° β=97.648(6)° γ=90.00°
Bis(ethyleneglycolato-O,O')tellurium(IV)
C4H8O4Te
Acta Crystallographica Section E (2013) 69, 7 o1080
a=6.4838(7)Å b=6.4978(8)Å c=15.3633(15)Å
α=90.00° β=102.168(11)° γ=90.00°
01354
C20H44B4F16Li4O10
Chemistry of Materials (2003) 15, 24 4685
a=19.720(2)Å b=8.9762(10)Å c=21.360(2)Å
α=90.00° β=102.607(2)° γ=90.00°
C7H9AuN4S2
C7H9AuN4S2
Crystal Growth & Design (2015) 15, 3 1422
a=6.3546(5)Å b=8.1890(6)Å c=11.3041(9)Å
α=77.928(2)° β=82.174(3)° γ=89.557(2)°
C7H9AuN4S2
C7H9AuN4S2
Crystal Growth & Design (2015) 15, 3 1422
a=6.3317(6)Å b=8.1709(8)Å c=11.3131(9)Å
α=77.949(3)° β=82.181(2)° γ=89.668(3)°
C40.25H52BClN6NiO1.25
C40.25H52BClN6NiO1.25
Organometallics (2003) 22, 23 4739-4743
a=11.914(3)Å b=12.596(4)Å c=15.042(4)Å
α=83.656(6)° β=86.246(6)° γ=64.511(6)°
C36H40BClN6Ni
C36H40BClN6Ni
Organometallics (2003) 22, 23 4739-4743
a=9.1756(10)Å b=10.9562(12)Å c=17.497(2)Å
α=102.601(2)° β=97.437(2)° γ=95.017(2)°
02054
C7H12.38F3LiO6S
Journal of the American Chemical Society (2003) 125, 12098-12099
a=10.0678(16)Å b=8.5275(14)Å c=14.399(2)Å
α=90.00° β=96.023(3)° γ=90.00°
02027y
C68H82B2Li2O10
Journal of the American Chemical Society (2003) 125, 12098-12099
a=12.5349(15)Å b=36.295(4)Å c=13.0899(15)Å
α=90.00° β=91.276(3)° γ=90.00°
Lithium perchlorate
ClLiO4
Inorganic Chemistry (2003) 42, 4522-4524
a=8.6447(12)Å b=6.8512(10)Å c=4.8254(7)Å
α=90.00° β=90.00° γ=90.00°
02102
C19H20N2O2,C0.5Cl2
Crystal Growth & Design (2004) 4, 6 1195-1201
a=25.263(5)Å b=5.6455(11)Å c=27.459(5)Å
α=90.00° β=99.117(4)° γ=90.00°
02095
C38H38N4O4,C6H6
Crystal Growth & Design (2004) 4, 6 1195-1201
a=22.407(7)Å b=6.061(2)Å c=27.148(9)Å
α=90.00° β=91.107(5)° γ=90.00°
02114a
C19H20N2O2,0.5C4H8O2
Crystal Growth & Design (2004) 4, 6 1195-1201
a=22.567(2)Å b=6.0016(6)Å c=27.224(3)Å
α=90.00° β=93.444(2)° γ=90.00°
Phenylbutazone tetrahydrofuran solvate
C19H20O2N2,0.5(C4H8O)
Crystal Growth & Design (2004) 4, 6 1195-1201
a=22.614(2)Å b=5.9811(6)Å c=27.193(3)Å
α=90.00° β=93.819(2)° γ=90.00°
Phenylbutazone cyclohexane solvate
C19H20N2O2,0.5(C6H12)
Crystal Growth & Design (2004) 4, 6 1195-1201
a=25.653(3)Å b=5.6091(7)Å c=27.551(4)Å
α=90.00° β=98.621(2)° γ=90.00°
{(CuBr)4([12]aneS4)2}
C8H16S4Br2Cu2
Journal of the Chemical Society, Dalton Transactions (2001) 4 456
a=7.295(7)Å b=13.464(3)Å c=15.200(3)Å
α=90.00° β=98.68(3)° γ=90.00°